Patrick Krause is a Director and Co-Head of MHT Partners’ Healthcare Services practice, where he focuses on specialty physician groups, post-acute care, and technology enabled healthcare services. Prior to joining MHT Partners, Patrick worked for Novartis’ Molecular Diagnostics group (now part of Grifols). Via finance and marketing roles, Patrick supported the Company’s ongoing blood-screening business and the development and market positioning of new products and services. From 2003 to 2011, he worked for Deloitte, where he served many of the firms largest healthcare clients. Through these engagements, Patrick provided an array of strategic, financial, and technology advisory services to healthcare leaders at hospitals, commercial payors, technology, and life sciences companies.
Patrick has undergraduate degrees in Economics and Organization Studies from the University of Michigan and an MBA from the Haas School of Business at the University of California, Berkeley.
–The Rise of Consumer IV Therapy Clinics
–Private Equity Investment in ENT Practices
–Technology and Home Health Trends Impacting the Diagnostic Device Industry
–Maximizing the Potential of Hospital Pricing Transparency Regulations
–Unlocking the Value of Protected Patient Data
–Blockchain for Healthcare Data
–Medical Device Companies | Thoughts on 2019 M&A Activity
–Private Equity-Backed Specialty Physician Platforms – Where do we go from here?
–Increasing Prevalence of Surgeries Performed in an ASC Setting . . . continued
–Increasing Prevalence of Surgeries Performed in an ASC Setting
–The Benefits and Increasing Prevalence of Ambulatory Surgery Centers
–Key Takeaways – MWE 12th Annual Health Care Services PE Symposium, Cont.
–Key Takeaways – MWE 12th Annual Health Care Services PE Symposium
–What Makes a Specialty Physician Practice Attractive to Private Equity Groups
–The Current Temperature of High-Tech Care
–Is It Time to Sell Your Practice? A Cont. from Last Week’s “Health Matters” Blog
–Is It Time to Sell Your Practice?
–Fertility Clinics Offer Big Potential for Investors and Physician Practices
–Investing in the Continuum of Care Can Be a Win-Win for Patients and Hospitals
–Data Analytics Can Help Practices Transition to Value-based Care Models
–Ambulatory-Surgery Centers Can Help Unlock Investment Value in Ortho Practices
–SwiftPath: Private Equity and ASC Joint Replacement
–Why PE Firms are Buying Orthopedic and Ophthalmology Practices
–What Should Dermatologists Do When a Merger Beckons?
–Crucial Considerations for Partnership or Sale
–Private Equity Firms are Suddenly Buying Dermatology Practices — Here’s Why